Therapeutic Action of Ghrelin in a Mouse Model of Colitis
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 130 (6) , 1707-1720
- https://doi.org/10.1053/j.gastro.2006.01.041
Abstract
No abstract availableKeywords
Funding Information
- Ministério da Educação e Ciência
- Consejería de Salud y Familias, Junta de Andalucía (PI04/0674)
- Fundación Ramón Areces
- Junta de Andalucía
This publication has 41 references indexed in Scilit:
- Circulating ghrelin levels in patients with inflammatory bowel diseaseGut, 2006
- Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell functionEuropean Journal of Immunology, 2004
- Antigen-specific regulatory T cells—their induction and role in infectionSeminars in Immunology, 2004
- Chronic inflammation modulates ghrelin levels in humans and ratsRheumatology, 2003
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- Role of chemokines and chemokine receptors in the gastrointestinal tractImmunology, 2002
- Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitisBritish Journal of Surgery, 2001
- Predominant pathogenic role of tumor necrosis factor in experimental colitis in miceEuropean Journal of Immunology, 1997
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995